Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge
- PMID: 18063449
- DOI: 10.1016/j.vaccine.2007.10.052
Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge
Abstract
The bacillus Calmette--Guerin (BCG), a live attenuated Mycobacterium bovis strain is considered a promising candidate as a vector system for delivery of foreign antigens to the immune system. The gene coding for the Leptospira interrogans external membrane protein LipL32, a highly immunogenic antigen found in all pathogenic leptospira, was cloned into several mycobacterial vectors for expression in BCG. Hamsters immunized with recombinant BCG (rBCG) expressing LipL32 were protected against mortality (P<or=0.05) upon challenge with a lethal inoculum of L. interrogans serovar Copenhageni. Autopsy examination did not reveal macroscopic or histological evidence of disease in rBCG immunized hamsters that survived lethal challenge. The data presented here further enhance the status of LipL32 as a promising candidate antigen for use in the control of leptospirosis, when presented to the immune system by an appropriate delivery system.
Similar articles
-
[Construction and expression of recombinant Mycobacterium bovis BCG with the ompA-like membrane protein gene Loa22 of Leptospira interrogans serovar].Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Mar;41(2):189-93. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20506632 Chinese.
-
Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.Biol Res. 2010;43(1):13-8. Epub 2010 May 7. Biol Res. 2010. PMID: 21157628
-
Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.Can J Microbiol. 2007 Apr;53(4):472-9. doi: 10.1139/w06-138. Can J Microbiol. 2007. PMID: 17612601
-
Protective immunity elicited by rBCG vaccines.Dev Biol Stand. 1994;82:163-70. Dev Biol Stand. 1994. PMID: 7958471 Review.
-
Recombinant BCG as an antigen delivery system.Cell Mol Biol (Noisy-le-grand). 1994;40 Suppl 1:31-6. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7950859 Review.
Cited by
-
Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy.Pathogens. 2023 May 31;12(6):787. doi: 10.3390/pathogens12060787. Pathogens. 2023. PMID: 37375478 Free PMC article. Review.
-
Leptospira borgpetersenii Leucine-Rich Repeat Proteins Provide Strong Protective Efficacy as Novel Leptospiral Vaccine Candidates.Trop Med Infect Dis. 2022 Dec 22;8(1):6. doi: 10.3390/tropicalmed8010006. Trop Med Infect Dis. 2022. PMID: 36668913 Free PMC article.
-
A New Recombinant Multiepitope Chimeric Protein of Leptospira interrogans Is a Promising Marker for the Serodiagnosis of Leptospirosis.Trop Med Infect Dis. 2022 Nov 9;7(11):362. doi: 10.3390/tropicalmed7110362. Trop Med Infect Dis. 2022. PMID: 36355904 Free PMC article.
-
Revisiting the Development of Vaccines Against Pathogenic Leptospira: Innovative Approaches, Present Challenges, and Future Perspectives.Front Immunol. 2022 Jan 3;12:760291. doi: 10.3389/fimmu.2021.760291. eCollection 2021. Front Immunol. 2022. PMID: 35046936 Free PMC article. Review.
-
TonB-dependent receptor epitopes expressed in M. bovis BCG induced significant protection in the hamster model of leptospirosis.Appl Microbiol Biotechnol. 2022 Jan;106(1):173-184. doi: 10.1007/s00253-021-11726-9. Epub 2021 Dec 11. Appl Microbiol Biotechnol. 2022. PMID: 34893930 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
